Tower Research Capital (TRC)’s Nobilis Health Corp. HLTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-9,845
Closed -$14K 4321
2017
Q3
$14K Buy
9,845
+245
+3% +$387 ﹤0.01% 2935
2017
Q2
$18K Sell
9,600
-48,161
-83% -$72.9K ﹤0.01% 1288
2017
Q1
$95K Buy
57,761
+46,661
+420% +$97K 0.01% 487
2016
Q4
$23K Buy
11,100
+10,700
+2,675% +$29.1K ﹤0.01% 2030
2016
Q3
$2K Sell
400
-11,109
-97% -$33.4K ﹤0.01% 3190
2016
Q2
$33K Sell
11,509
-184
-2% -$597 ﹤0.01% 1873
2016
Q1
$36K Buy
11,693
+11,255
+2,570% +$29.1K 0.01% 960
2015
Q4
$1K Sell
438
-227
-34% -$726 ﹤0.01% 4264
2015
Q3
$3K Sell
665
-14,335
-96% -$82.3K ﹤0.01% 3217
2015
Q2
$127K Buy
+15,000
New +$106K 0.01% 632

Other funds holding HLTH

Tower Research Capital (TRC)'s HLTH Position: Q4 2017 in Review

Tower Research Capital (TRC) sold out of Nobilis Health Corp. (HLTH) in Q4 2017, closing a stake of 9,845 shares — an estimated $14K sold.

Tower Research Capital (TRC) first reported a position in HLTH in Q2 2015 and held it in 10 quarters. The position peaked at $127K in Q2 2015. 40 funds tracked by Wall St. Rank hold HLTH as of Q4 2017.

  • Tower Research Capital (TRC) reported no remaining Nobilis Health Corp. position as of Q4 2017 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 9,845 Nobilis Health Corp. shares in Q4 2017, an estimated $14K.
  • Tower Research Capital (TRC) first reported a position in Nobilis Health Corp. in Q2 2015 and held it in 10 quarters.
  • Tower Research Capital (TRC)'s Nobilis Health Corp. position peaked at $127K in Q2 2015.
  • 40 funds tracked by Wall St. Rank held Nobilis Health Corp. as of Q4 2017.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2017, filed 9 Feb 2018.